The main aim of WP2 will be to design, prepare and characterize new formulations with antimicrobial functionality. For developing these, printing technologies will be exploited. New formulations will be directly applied to counteract BRIs in medical devices. Proof-of-concept endotracheal catheters and femur implants will be fabricated with 3D-printing incorporated antimicrobials. Alternatively, bioprinting will be utilized to coat 3D- printed devices. Based on in vitro functionality studies, the best candidate formulations will be chosen for WP3.
WP2: Development of 3D printed devices and formulations
- PRINT-AID at EUROPEAN RESEARCHERS’ NIGHT 2016 2017-01-20 13:32:15
- PRINT-AID KICKED-OFF Jan 18th-19th 2017 2017-01-20 08:41:00
- 2.3 MILLION EUROS TO DEVELOP 3D PRINTING OF ANTI-INFECTIVE MEDICAL DEVICES 2016-05-10 08:41:00
- PRINT-AID publications to appear soon 2017-02-03 08:41:00